
ŌURA Snags $200M, Hits $5.2B Valuation
Fidelity Management & Research Company and Dexcom participated in ŌURA’s $200 million Series D round.
Fidelity Management & Research Company and Dexcom participated in ŌURA’s $200 million Series D round.
MIT spinout Bloomer Tech is developing a wearable electrocardiogram device designed to look and feel like a bra.
A new report from Relatient, A Data-Driven Guide to Patient Access Succes, highlights how focusing on data accuracy and relevance can enhance the performance of healthcare practices.
Wearable technology seems to offer great potential for early detection and management of agitation experienced by people with communication-impaired neurological disorders, allowing caregivers to provide personalized interventions that could significantly improve patients’ lives.
ŌURA announced two new heart health features on Friday: one that estimates cardiovascular age and one that measures cardio capacity.
Pharmaceutical companies use Feel Therapeutics’ technology to monitor the mental state of participants in clinical trials of behavioral medications. But the startup envisions its technology eventually also finding a place as a part of clinical care.
Biolinq raked in $58 million in capital this week. The company is developing a wearable patch that uses electrochemical sensors to measure a person’s glucose levels from the intradermal space just beneath the surface of their skin.
Oura — a company selling a ring that tracks peoples’ biometrics — announced new partnerships with three providers of continuous glucose monitors: January, Supersapiens and Veri. These companies will now be receiving sleep scores and other biometric data from Oura so they can see how these measurements affect users’ glucose levels and overall health.
Wearables company Movano Health recently partnered with Novant Health to beta test its smart ring — which is designed for women — with the health system’s employees. The program is expected to prepare Movano for its first direct-to-consumer product launch in the first half of next year.
Cala Health recently published a post-market study showing that its wrist-based wearable to treat essential tremor effectively reduced patients' tremor power with no loss of effect over time. Most patients involved in the study reported improvement in daily activities, such as eating, drinking, texting and writing.
Among consumers, wearables are growing in popularity. But what can clinicians actually gain from the data the devices collect? Panelists at the Connected Health Conference in Boston weighed in.
This was but one of several pieces of news the Amsterdam-based technology company discussed Monday at HIMSS17.
While consumers dabble in the cool features and sleek user interface of their wearables, healthcare providers continue to ask one important question: Does this tsunami of patient-generated data ultimately belong in the medical record?
Dr. Dave Albert demonstrated the replacement Apple Watch wristband Friday at the USC Center for Body Computing conference in Los Angeles.
Wearables are starting to pop up everywhere in medicine — except, perhaps, actual clinical settings. Even a staid organization like the American Psychiatric Association had some on hand at its 168th annual meeting this week, as this video illustrates.
Apparently some people have a difficult time determining whether or not their body odor is in the socially acceptable, non-offensive range. Or at least Google believes enough helpless stinkers are out there, and they could really use a little help. Google has been awarded a patent for a wearable “fragrance emission device” that not only […]